🇫🇷 Rimegepant 75mg daily dosing in France

Rimegepant 75mg daily dosing (rimegepant-75mg-daily-dosing) regulatory status in France.

Marketing authorisation

ANSM

  • Status: approved

Rimegepant 75mg daily dosing in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in France

Frequently asked questions

Is Rimegepant 75mg daily dosing approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for Rimegepant 75mg daily dosing in France?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.